---
title: "Tradr 2X Long SNPS Daily ETF (SNPX.US)"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/SNPX.US.md"
symbol: "SNPX.US"
name: "Tradr 2X Long SNPS Daily ETF"
industry: "Biotechnology"
datetime: "2026-05-20T05:55:12.340Z"
locales:
  - [en](https://longbridge.com/en/quote/SNPX.US.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/SNPX.US.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/SNPX.US.md)
---

# Tradr 2X Long SNPS Daily ETF (SNPX.US)

## Company Overview

TAO Synergies Inc. operates as a biopharmaceutical company. The company is primarily focused on developing a product platform based upon Bryostatin-1, for the treatment of Alzheimer’s disease (AD), which is in the clinical testing stage. It is also evaluating potential therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as Fragile X syndrome, Multiple Sclerosis (MS), and Niemann-Pick Type C disease, which have undergone pre-clinical testing.

| Item | Detail |
|------|--------|
| Industry | Biotechnology |
| Exchange | US Market |

## Key Drivers
> *AI-analyzed key factors driving this stock's performance*


## Longbridge Financial Score™: 
> *Longbridge Financial Score™ — Proprietary multi-factor rating model by Longbridge*
> Updated: 1970-01-01T00:00:00.000Z

**Overall:  (0.00)**

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| PE (TTM) | -0.84 | 228 | - | - | - |
| PB | 2.11 | 261 | 2.11 | 2.11 | 2.11 |
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Analyst Rating Distribution

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 24.55 |
| Highest Target | 14.00 |
| Lowest Target | 14.00 |

## References

- [Company Overview — Profile, executives, shareholders, business breakdown](https://longbridge.com/en/quote/SNPX.US/overview.md)
- [Financial Reports — Income, balance sheet, cash flow, dividends](https://longbridge.com/en/quote/SNPX.US/norm.md)
- [Related News](https://longbridge.com/en/quote/SNPX.US/news.md)
- [Filings — Company announcements and regulatory filings](https://longbridge.com/en/quote/SNPX.US/filings.md)

---

> **Disclaimer: This article is for reference only and does not constitute any investment advice.**